Figure 5.
Predicted and observed time-concentration profiles of tozadenant after optimization, (a) intravenous administration at a dose of 5 mg/kg, (b) oral administration at a dose of 1 mg/kg, (c) oral administration at a dose of 5 mg/kg in rats.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.